Literature DB >> 2593772

Gelatin particle agglutination assay for HIV antibodies: a rapid, economical modification with increased sensitivity.

J A Barbara, R Salker, P Challis, M Contreras.   

Abstract

Modification of a commercial gelatin particle agglutination assay for anti-HIV reduces the test time to 30 min, increases the sensitivity sevenfold without any prozoning, and maintains specificity while cutting the cost of the test by 90%. The modification involves a tenfold dilution of the gelatin particles, which are added to a dilution of test serum in a 'V' well standard microplate. After incubation, plates are centrifuged briefly and allowed to stand at an inclination of 70 degrees until positive and negative reactions are clearly distinguishable within approximately 15 min.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2593772

Source DB:  PubMed          Journal:  Med Lab Sci        ISSN: 0308-3616


  5 in total

1.  Measuring HIV-1 seroprevalence among English newborns: blood spot size.

Authors:  C McGarrigle; J Parry; A Nicoll
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

2.  Unlinked anonymous HIV study of hospital patients and general practice attenders in Glasgow, 1991-1997.

Authors:  J Johnston; S Cameron; M Stewart; D Goldberg; C Fletcher; W Smyth; G Codere
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

3.  HIV infection among homosexual/bisexual males attending genitourinary clinics in Scotland.

Authors:  D Goldberg; G Scott; M Weir; S Cameron; J Peutherer; A McMillan; G Leadbetter; A Scoular; G Codere; G Allardice
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

4.  Modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards.

Authors:  S P Parker; W D Cubitt
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

5.  Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.

Authors:  M Brennan; J Runganga; J A Barbara; M Contreras; R S Tedder; J A Garson; P W Tuke; P P Mortimer; L McAlpine; J H Tosswill
Journal:  BMJ       Date:  1993-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.